New Jersey
Merck's stock rises on sales of its blockbuster cancer drug Keytruda
Merck’s stock jumped 3% to about $130 during Thursday morning trading after the New Jersey-based pharmaceutical company reported higher than expected sales of its blockbuster cancer drug Keytruda.Read more...
Mercks stock jumped 3% to about $130 during Thursday morning trading after the New Jersey-based pharmaceutical company reported higher than expected sales of its blockbuster cancer drug Keytruda.
Sa… [+1635 chars]
Related
Share this page
Guest Posts by Easy Branches
